Cobicistat News
Cobicistat currently has 2 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Cobicistat with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1...
- Evidence level: L5
- Predicted indications (20):
- HIV infectious disease (100.0%)
- feline acquired immunodeficiency syndrome (99.9%)
- simian immunodeficiency virus infection (99.9%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (99.9%)
- AIDS (99.2%)
- chronic hepatitis C virus infection (98.7%)
- congenital human immunodeficiency virus (98.3%)
- AIDS related complex (98.3%)
- hepatitis C virus infection (97.0%)
- obsolete familial combined hyperlipidemia (96.8%)
- hepatitis B virus infection (96.5%)
- hepatitis E virus infection (96.2%)
- hepatitis A virus infection (96.1%)
- Omsk hemorrhagic fever (96.0%)
- hepatitis, viral, animal (96.0%)
- Kyasanur forest disease (95.9%)
- fibroma of prostate (92.7%)
- Brenner tumor (92.4%)
- benign reproductive system neoplasm (92.4%)
- benign prostate phyllodes tumor (92.0%)
Related News (2)
Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau - The Guardian
2026-10-09 hepatitis
Source: The Guardian
Meteo estremo, cibo contaminato, ricoveri lunghi. A Roma è boom di Epatite A: perché c’è da preoccuparsi
2026-10-08 epatite
Source: RomaToday
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.